000			02173 a2200649 4500
005			20250517153931.0
264		0	_c20171113
008			201711s 0 0 eng d
022			_a1097-4652
024	7		_a10.1002/jcp.26001 _2doi
040			_aNLM _beng _cNLM
100	1		_aVelmurugan, Bharath K
245	0	0	_aPP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential. _h[electronic resource]
260			_bJournal of cellular physiology _cFeb 2018
300			_a1300-1311 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme Activation
650	0	4	_aEnzyme Activators _xpharmacology
650	0	4	_aFemale
650	0	4	_aFingolimod Hydrochloride _xpharmacology
650	0	4	_aGlycogen Synthase Kinase 3 beta _xmetabolism
650	0	4	_aHead and Neck Neoplasms _xdrug therapy
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMouth Neoplasms _xdrug therapy
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Staging
650	0	4	_aOdds Ratio
650	0	4	_aPhosphorylation
650	0	4	_aProportional Hazards Models
650	0	4	_aProtein Phosphatase 2 _xmetabolism
650	0	4	_aRisk Factors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSquamous Cell Carcinoma of Head and Neck
650	0	4	_aTime Factors
650	0	4	_aTyrosine
700	1		_aLee, Chien-Hung
700	1		_aChiang, Shang-Lun
700	1		_aHua, Chun-Hung
700	1		_aChen, Mei-Chung
700	1		_aLin, Shu-Hui
700	1		_aYeh, Kun-Tu
700	1		_aKo, Ying-Chin
773	0		_tJournal of cellular physiology _gvol. 233 _gno. 2 _gp. 1300-1311
856	4	0	_uhttps://doi.org/10.1002/jcp.26001 _zAvailable from publisher's website
999			_c27185136 _d27185136